Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. [electronic resource]
Producer: 20000616Description: 1783-8 p. digitalISSN:- 0021-972X
- Absorptiometry, Photon
- Administration, Intranasal
- Alendronate -- adverse effects
- Alkaline Phosphatase -- blood
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone and Bones -- metabolism
- Calcitonin -- administration & dosage
- Collagen -- urine
- Collagen Type I
- Female
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Peptides -- urine
- Placebos
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.